Navigation Links
Mass. General's Warren Triennial Prize honors discoverers of microRNAs
Date:9/10/2008

Two investigators who helped to uncover a previously unsuspected world of tiny RNA molecules will be recognized next month by Massachusetts General Hospital (MGH) with its highest award for research. Victor Ambros, PhD, of the University of Massachusetts Medical School, and Gary Ruvkun, PhD, of the MGH Department of Molecular Biology, are receiving the 2008 Warren Triennial Prize in honor of their discovering that microRNAs play a crucial role in controlling the activity of important genes. The awardees will speak at an October 29 scientific symposium at the hospital's Simches Research Center.

First established in 1871, the Warren Triennial Prize is named for John Collins Warren, a co-founder of the MGH and its first surgeon, who performed the first surgical operation on a patient under ether anesthesia. Over the years, 22 Warren Triennial recipients have also received the Nobel Prize most recently 2004 receipients Craig Mello, PhD, and Andrew Fire, PhD, who subsequently received the 2006 Nobel. This year the celebration has been expanded to include an evening reception and dinner, featuring a talk by Nobel-Prize-winning geneticist Phillip A. Sharp, PhD, of Massachusetts Institute of Technology and an MGH trustee, and the award itself increased to $50,000 for each recipient.

Working in collaboration and independently over the past two decades, Ambros and Ruvkun were the first to find that tiny segments of RNA can turn off other genes by binding to the target genes' RNA. The mechanism they first discovered in the roundworm C. elegans was subsequently shown to apply to animals ranging from flies to mollusks to fish to humans. It now appears that the human genome contains between 500 and 1,000 of these microRNAs, which are involved in a broad range of normal and pathological activities and just beginning to be explored for the diagnosis, prognosis and treatment of diseases. Ambros is a Professor of Molecular Medicine at the University of Massachusetts Medical School and Ruvkun is a Professor of Genetics at Harvard Medical School.


'/>"/>

Contact: Sue McGreevey
smcgreevey@partners.org
617-724-2764
Massachusetts General Hospital
Source:Eurekalert

Related biology news :

1. Mass. General study shows how exercise changes structure and function of heart
2. ETH Zurich professor Ari Helenius awarded Benoist Prize
3. Columbia to award 2007 Horwitz Prize to three generations of teacher-student scientists
4. Gene-targeting pioneer Mario Capecchi shares 2007 Nobel Prize in Medicine
5. Professor Sir Martin Evans wins Nobel Prize for Medicine
6. Gregory Hannon wins 2007 Paul Marks Prize for contributions to understanding and treating cancer
7. Nobel Peace Prize 2007 to intergovernmental panel on climate change
8. NARSAD presents 2007 prizes for outstanding achievement in neuroscience and psychiatric research
9. Neilson member of Nobel Prize-winning panel of scientists
10. Maynard Olson receives $500,000 Gruber Genetics Prize
11. Shigetada Nakanishi receives $500,000 Gruber Neuroscience Prize
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/22/2017)... , Feb. 22, 2017 With ... 2021, ABI Research identifies four technologies that innovative ... to secure significant share in the changing competitive ... and passive authentication.   "Companies can ... comes to security," says Dimitrios Pavlakis , ...
(Date:2/14/2017)... , Feb. 14, 2017  Wake Forest Baptist Medical ... its new chief executive officer (CEO). Freischlag joins the ... John D. McConnell , M.D., who last year announced ... the Medical Center, after leading it since 2008.   ... scope of Wake Forest Baptist,s academic health system, which ...
(Date:2/9/2017)... LONDON , Feb. 9, 2017 The ... in-depth analysis of the biomass boiler market globally in ... sales of biomass boilers. The market for biomass boilers ... product type, end-user, application, and country/region. The market based ... agriculture & forest residues, biogas & energy crops, urban ...
Breaking Biology News(10 mins):
(Date:3/23/2017)... 2017 In today,s pre-market research, ... the Biotech industry: Sangamo Therapeutics Inc. (NASDAQ: SGMO), Eyegate ... SYN), and Regulus Therapeutics Inc. (NASDAQ: RGLS ... Suisse upgraded its rating on Pharmaceuticals/Biotechnology to "Overweight" from "Market Weight." Learn ... at: ...
(Date:3/22/2017)... Calif. , March 22, 2017  UBM ... proud to announce their extended partnership and the ... be headlined by the 21 st Annual ... Boston, taking place May 3-4, 2017. ... Medical Technology Association (ADVAMED) President and CEO, ...
(Date:3/22/2017)... , March 22, 2017 MarketNewsUpdates.com News ... ... conditions are being pressured as of late due to the ... pain management has a dramatic impact on patient,s quality of ... development activities for identifying new forms of opioid formulations that ...
(Date:3/22/2017)... ... March 21, 2017 , ... Okyanos Cell Therapy has announced ... of their live events series, “Stem Cell Therapy: The Next Phase in the Evolution ... 2013 Stem Cell Research and Therapy Act, Okyanos maintains a mission to ...
Breaking Biology Technology: